If the answer is innovation, why can't we define it?
In a recent report , Britain’s NICE (National Institute for Health and Clinical Excellence) has just touched on the tipping point for how pharma will handle the approaching... Read more
In a recent report , Britain’s NICE (National Institute for Health and Clinical Excellence) has just touched on the tipping point for how pharma will handle the approaching... Read more
Shirly S. Wang writes for the WSJ Health Blog : "It's no secret that the biotech industry has been hurting during the economic downturn as investor dollars slowed to a trickle. As of March, 120... Read more
CROs like to throw around the word “transparency,” but true visibility into what is happening during the course of a clinical trial can still be hard to come by. ClinPage’s... Read more